|
시장보고서
상품코드
2110057
외래 주입 센터 시장(2026-2030년)Global Ambulatory Infusion Center Market 2026-2030 |
||||||
세계의 외래 주입 센터 시장은 2025년부터 2030년까지 160억 8,630만 달러 증가하고, 예측 기간 동안 CAGR은 5.6%에 달할 것으로 예측됩니다.
전 세계 외래 주입 센터 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 업체 분석을 제공합니다.
본 보고서는 현재 시장 상황, 최신 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장은 만성 질환 및 복잡한 병태의 유병률 증가, 경제적 압박과 비용 효율적인 외래 진료로의 전환, 수액 주입 장치의 기술적 진보, 그리고 디지털 헬스와의 통합에 의해 주도되고 있습니다.
본 조사는 업계 주요 관계자들의 의견을 포함한 1차 정보 및 2차 정보를 객관적으로 조합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석이 포함된 부문별 데이터, 그리고 벤더 현황이 수록되어 있습니다. 또한, 과거 데이터 및 예측 데이터도 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 대상 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 5.4% |
| CAGR | 5.6% |
| 증가액 | 160억 8,630만 달러 |
본 조사에서는 향후 수년간 전 세계 외래 주입 센터 시장의 성장을 견인할 주요 요인 중 하나로, 전문적인 수액 네트워크의 확대 및 분산형 외래 진료 모델의 보급을 꼽고 있습니다. 또한, 디지털 헬스 생태계의 통합과 재고 관리 자동화, 바이오시밀러 제제의 채택 확대, 그리고 보험 적용 범위 확대로 인해 시장에서 상당한 수요가 발생할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 유형별
제9장 시장 세분화 : 적응증별
제10장 시장 세분화 : 치료법별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSMThe global ambulatory infusion center market is forecasted to grow by USD 16086.3 mn during 2025-2030, accelerating at a CAGR of 5.6% during the forecast period. The report on the global ambulatory infusion center market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases and complex conditions, economic pressures and shift toward cost-effective outpatient settings, technological advancements in infusion devices and digital health integration.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 5.4% |
| CAGR | 5.6% |
| Incremental Value | $16086.3 mn |
Technavio's global ambulatory infusion center market is segmented as below:
By Type
- Independent centers
- Hospitals
- Home healthcare
By Indication
- Oncology
- Autoimmune disorders
- Infectious diseases
- Neurological disorders
- Chronic pain conditions
By Therapy
- Immunoglobulin therapy
- Anti-infective therapy
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of dedicated specialty infusion networks and decentralized outpatient care models as one of the prime reasons driving the global ambulatory infusion center market growth during the next few years. Also, integration of digital health ecosystems and automated inventory management and rising adoption of biosimilar therapeutics and expanded payer coverage frameworks will lead to sizable demand in the market.
The report on the global ambulatory infusion center market covers the following areas:
- Global ambulatory infusion center market sizing
- Global ambulatory infusion center market forecast
- Global ambulatory infusion center market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ambulatory infusion center market vendors that include Cedars Sinai Health System, Community Health Systems Inc., CVS Health Corp., HCA Healthcare Inc., Infusion for Health, IVX Health, Mayo Clinic, McKesson Corp., Metro Infusion Center, Northwestern Medicine, Option Care Health Inc., Sutter Health, Tenet Healthcare Corp., The Cigna Group, The Cleveland Clinic Foundation, The Johns Hopkins Health System, United Health Group Inc.. Also, the global ambulatory infusion center market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Ambulatory Infusion Center Market 2020 - 2024
- Historic Market Size - Data Table on Global Ambulatory Infusion Center Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
- 5.4 Therapy segment analysis 2020 - 2024
- Historic Market Size - Therapy Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global ambulatory infusion center market
- 6.2 Impact of geopolitical conflicts on global ambulatory infusion center market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Independent centers - Market size and forecast 2025-2030
- 8.4 Hospitals - Market size and forecast 2025-2030
- 8.5 Home healthcare - Market size and forecast 2025-2030
- 8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Indication
- 9.1 Market segments
- 9.2 Comparison by Indication
- 9.3 Oncology - Market size and forecast 2025-2030
- 9.4 Autoimmune disorders - Market size and forecast 2025-2030
- 9.5 Infectious diseases - Market size and forecast 2025-2030
- 9.6 Neurological disorders - Market size and forecast 2025-2030
- 9.7 Chronic pain conditions - Market size and forecast 2025-2030
- 9.8 Market opportunity by Indication
- Market opportunity by Indication ($ million)
10 Market Segmentation by Therapy
- 10.1 Market segments
- 10.2 Comparison by Therapy
- 10.3 Immunoglobulin therapy - Market size and forecast 2025-2030
- 10.4 Anti-infective therapy - Market size and forecast 2025-2030
- 10.5 Others - Market size and forecast 2025-2030
- 10.6 Market opportunity by Therapy
- Market opportunity by Therapy ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Taiwan - Market size and forecast 2025-2030
- 12.5.6 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 UAE - Market size and forecast 2025-2030
- 12.6.6 New Zealand - Market size and forecast 2025-2030
- 12.6.7 Chile - Market size and forecast 2025-2030
- 12.6.8 Egypt - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising prevalence of chronic diseases and complex conditions
- Economic pressures and shift toward cost-effective outpatient settings
- Technological advancements in infusion devices and digital health integration
- 13.2 Market challenges
- Complex and restrictive reimbursement frameworks
- Severe workforce shortages and specialized staffing limitations
- Intense competition and regulatory compliance burdens
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of dedicated specialty infusion networks and decentralized outpatient care models
- Integration of digital health ecosystems and automated inventory management
- Rising adoption of biosimilar therapeutics and expanded payer coverage frameworks
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Cedars Sinai Health System
- Cedars Sinai Health System - Overview
- Cedars Sinai Health System - Product / Service
- Cedars Sinai Health System - Key offerings
- SWOT
- 15.5 Community Health Systems Inc.
- Community Health Systems Inc. - Overview
- Community Health Systems Inc. - Product / Service
- Community Health Systems Inc. - Key offerings
- SWOT
- 15.6 CVS Health Corp.
- CVS Health Corp. - Overview
- CVS Health Corp. - Business segments
- CVS Health Corp. - Key offerings
- CVS Health Corp. - Segment focus
- SWOT
- 15.7 HCA Healthcare Inc.
- HCA Healthcare Inc. - Overview
- HCA Healthcare Inc. - Product / Service
- HCA Healthcare Inc. - Key offerings
- SWOT
- 15.8 IVX Health
- IVX Health - Overview
- IVX Health - Product / Service
- IVX Health - Key offerings
- SWOT
- 15.9 Mayo Clinic
- Mayo Clinic - Overview
- Mayo Clinic - Product / Service
- Mayo Clinic - Key offerings
- SWOT
- 15.10 McKesson Corp.
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
- SWOT
- 15.11 Northwestern Medicine
- Northwestern Medicine - Overview
- Northwestern Medicine - Product / Service
- Northwestern Medicine - Key offerings
- SWOT
- 15.12 Option Care Health Inc.
- Option Care Health Inc. - Overview
- Option Care Health Inc. - Product / Service
- Option Care Health Inc. - Key offerings
- SWOT
- 15.13 Sutter Health
- Sutter Health - Overview
- Sutter Health - Product / Service
- Sutter Health - Key offerings
- SWOT
- 15.14 Tenet Healthcare Corp.
- Tenet Healthcare Corp. - Overview
- Tenet Healthcare Corp. - Business segments
- Tenet Healthcare Corp. - Key offerings
- Tenet Healthcare Corp. - Segment focus
- SWOT
- 15.15 The Cigna Group
- The Cigna Group - Overview
- The Cigna Group - Business segments
- The Cigna Group - Key offerings
- The Cigna Group - Segment focus
- SWOT
- 15.16 The Cleveland Clinic Foundation
- The Cleveland Clinic Foundation - Overview
- The Cleveland Clinic Foundation - Product / Service
- The Cleveland Clinic Foundation - Key offerings
- SWOT
- 15.17 The Johns Hopkins Health System
- The Johns Hopkins Health System - Overview
- The Johns Hopkins Health System - Product / Service
- The Johns Hopkins Health System - Key offerings
- SWOT
- 15.18 United Health Group Inc.
- United Health Group Inc. - Overview
- United Health Group Inc. - Business segments
- United Health Group Inc. - Key offerings
- United Health Group Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
